Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Stephanie L. Harrison; Benjamin J. R. Buckley; Leona A. Ritchie; Riccardo Proietti; Paula Underhill; Deirdre A. Lane; Professor Gregory Lip

doi:10.1111/jgs.17884

Back

Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Article 2022 en

Abstract

1 min read

The proportion of people aged ≥80 years receiving OAC has increased since the introduction of NOACs, but remains low. Use of a NOAC was associated with improved outcomes compared to warfarin, and compared to no OAC, except for a small but statistically significant higher risk of major bleeding.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2023

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Tze‐Fan Chao, Ling Kuo, Professor Gregory Lip, S A Chen

Article2021

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Preprint2023

Temporal trends of stroke severity and the association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation

Jo‐Nan Liao, Yi‐Hsin Chan, Ling Kuo, Chuan-Tsai Tsai, Chih‐Min Liu, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen, Tze‐Fan Chao

Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Abstract

Discussion(0)

Related publications

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Temporal trends of stroke severity and the association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation